Tumor Uptake of (64)Cu-DOTA-Trastuzumab in Patients with Metastatic Breast Cancer

The goal of this study was to characterize the relationship between tumor uptake of (64)Cu-DOTA-trastuzumab as measured by PET/CT and standard, immunohistochemistry (IHC)-based, histopathologic classification of human epidermal growth factor receptor 2 (HER2) status in women with metastatic breast c...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Nucl Med
Main Authors: Mortimer, Joanne E., Bading, James R., Park, Jinha M., Frankel, Paul H., Carroll, Mary I., Tran, Tri T., Poku, Erasmus K., Rockne, Russell C., Raubitschek, Andrew A., Shively, John E., Colcher, David M.
Formato: Artigo
Idioma:Inglês
Publicado em: Society of Nuclear Medicine 2018
Assuntos:
Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5750523/
https://ncbi.nlm.nih.gov/pubmed/28637802
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.117.193888
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados